Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,875 | 10,061 | 5,717 | 8,368 | 11,293 |
| TOTAL | $7,645 | $10,474 | $6,688 | $9,338 | $12,187 |
| Non-Current Assets | |||||
| PPE Net | 229 | 245 | 1,497 | 1,576 | 1,423 |
| Intangibles | 1,676 | 1,676 | 1,676 | 1,676 | 1,676 |
| Other Non-Current Assets | 12 | 478 | 12 | 12 | 12 |
| TOTAL | $1,916 | $2,398 | $3,184 | $3,264 | $3,111 |
| Total Assets | $9,561 | $12,872 | $9,871 | $12,601 | $15,297 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,884 | 1,868 | 2,019 | 1,466 | 1,186 |
| Other current liabilities | 132 | 105 | 111 | 120 | 210 |
| TOTAL | $2,108 | $2,115 | $2,133 | $1,589 | $1,399 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 89 | 139 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 143 | 144 | 145 |
| TOTAL | $1 | $2 | $146 | $148 | $150 |
| Total Liabilities | $2,109 | $2,117 | $2,279 | $1,737 | $1,548 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6 | 6 | 5 | 5 | 4 |
| Retained earnings | -87,825 | -84,349 | -80,271 | -76,800 | -73,678 |
| TOTAL | $7,452 | $10,755 | $7,593 | $10,865 | $13,749 |
| Total Liabilities And Equity | $9,561 | $12,872 | $9,871 | $12,601 | $15,297 |